CRH MEDICAL CORP's ticker is CRHM and the CUSIP is 12626F105. A total of 45 filers reported holding CRH MEDICAL CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $15,645,000 | +25.5% | 3,958,612 | -26.0% | 0.10% | +16.7% |
Q4 2020 | $12,462,000 | +47.6% | 5,348,770 | +37.5% | 0.08% | +23.5% |
Q3 2020 | $8,444,000 | +2.5% | 3,891,262 | -2.2% | 0.07% | 0.0% |
Q2 2020 | $8,239,000 | +44.5% | 3,980,642 | -6.5% | 0.07% | +28.3% |
Q1 2020 | $5,703,000 | -62.4% | 4,256,362 | -2.6% | 0.05% | -39.1% |
Q4 2019 | $15,161,000 | +8.8% | 4,369,350 | -3.6% | 0.09% | -10.3% |
Q3 2019 | $13,930,000 | -49.5% | 4,533,850 | -50.6% | 0.10% | +15.5% |
Q2 2019 | $27,606,000 | +10.6% | 9,175,900 | -2.9% | 0.08% | -10.6% |
Q1 2019 | $24,962,000 | +59.0% | 9,449,920 | +84.3% | 0.09% | -29.9% |
Q4 2018 | $15,703,000 | -20.3% | 5,127,100 | +3.5% | 0.13% | -5.6% |
Q3 2018 | $19,703,000 | -37.6% | 4,955,130 | -50.9% | 0.14% | +21.4% |
Q2 2018 | $31,572,000 | +141.0% | 10,097,000 | +94.7% | 0.12% | +18.2% |
Q1 2018 | $13,103,000 | -5.5% | 5,186,400 | -1.1% | 0.10% | +200.0% |
Q4 2017 | $13,869,000 | – | 5,244,700 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STADIUM CAPITAL MANAGEMENT LLC | 2,182,483 | $6,657,000 | 2.76% |
Pacific Ridge Capital Partners, LLC | 1,839,473 | $5,610,000 | 1.87% |
Nantahala Capital Management | 6,534,155 | $20,028,000 | 0.62% |
Beutel, Goodman & Co Ltd. | 5,127,100 | $15,703,000 | 0.13% |
PALLADIUM PARTNERS LLC | 207,900 | $634,000 | 0.05% |
Connor, Clark & Lunn Investment Management Ltd. | 2,201,799 | $6,739,000 | 0.05% |
Spark Investment Management LLC | 172,000 | $527,000 | 0.04% |
SEIZERT CAPITAL PARTNERS, LLC | 170,842 | $521,000 | 0.02% |
Sepio Capital, LP | 97,844 | $298,000 | 0.02% |
STIFEL FINANCIAL CORP | 2,116,607 | $6,459,000 | 0.02% |